🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to compare the efficacy and safety of lenalidomide plus CHO...
Status
Recruiting
Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2021-04-01
Trial ID
NCT04922567
Treatments Being Tested
This is a prospective, single-arm, phase II study, and the purpose of this ...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2023-10-24
Trial ID
NCT06176729
Treatments Being Tested
This prospective，multi-center，open-label, controlled study will evaluate th...
Status
Unknown
Location
Department of Hematology, Peking University Third Hospital, Beijing, China
Start Date
2020-07-29
Trial ID
NCT04480099
This is a phase II, non-randomized, single institution study in symptomatic...
Status
Completed
Location
University Health Network - Princess Margaret Hospital
Start Date
2010-05
Trial ID
NCT01133743
Treatments Being Tested
This is a Phase 3, randomized (study drug assigned by chance), open-label (...
Status
Active Not Recruiting
Location
Chru Jean Minjoz
Start Date
2019-10-17
Trial ID
NCT03993912
To evaluate the 6-month overall survival, safety, and tolerability of lenal...
Status
Completed
Location
Florida Cancer Specialists
Start Date
2009-02
Trial ID
NCT00837031
Treatments Being Tested
This phase II study investigating the efficacy and safety of a combination ...
Status
Withdrawn
Location
Sun Yat-sen University Cancer Center
Start Date
2016-12
Trial ID
NCT02986451
Treatments Being Tested
This is a multicenter prospective single arm phase II study, and the purpos...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2024-06-20
Trial ID
NCT06454968
Treatments Being Tested
The goal of this phase 2 trial is to test the safety and efficacy of G-Pola...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-24
Trial ID
NCT06665217
This is phase 1/2 study for patients with CLL or (SLL) who have not been pr...
Status
Withdrawn
Location
UC San Diego Moores Cancer Center
Start Date
2018-02
Trial ID
NCT02371590
Treatments Being Tested